Hydrocortisone Activase Pharmaceuticals (Hydrocortisone)

Hydrocortisone Activase Pharmaceuticals is used orally for conditions where glucocorticoid replacement or anti‑inflammatory effects are required.

• Replacement therapy in primary or secondary adrenal insufficiency to maintain normal cortisol levels.
• Management of acute inflammatory episodes such as severe allergic reactions, including angioedema and anaphylaxis.
• Treatment of chronic inflammatory disorders like rheumatoid arthritis or systemic lupus erythematosus when other therapies are insufficient or contraindicated.
• Adjunct therapy for certain dermatologic conditions that respond to systemic steroids, such as severe psoriasis or eczema.
• Supportive care in shock, severe stress, or postoperative periods where endogenous cortisol production may be inadequate.

• Hydrocortisone Activase Pharmaceuticals delivers hydrocortisone, a synthetic analogue of endogenous cortisol. After oral absorption, the drug binds to intracellular glucocorticoid receptors, forming a receptor‑ligand complex that translocates to the nucleus. This complex interacts with glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins and suppressing pro‑inflammatory cytokines. The overall effect reduces leukocyte migration, vascular permeability, and immune activation, thereby restoring hormonal balance in deficient states.

Oral hydrocortisone may cause a range of adverse reactions, which are generally classified by frequency and severity, and should be monitored by healthcare professionals.

Common

• Increased appetite or mild weight gain, often noticeable after several weeks of therapy.
• Fluid retention causing mild peripheral edema, especially in the lower extremities.
• Elevated blood glucose levels, which may require monitoring in diabetic patients.
• Mood changes such as irritability, anxiety, or difficulty sleeping.

Serious

• Severe allergic reaction (anaphylaxis) presenting with widespread rash, facial swelling, or difficulty breathing, requiring immediate medical attention.
• Signs of infection, such as fever or persistent cough, and worsening hypertension due to fluid overload or vascular effects.

When prescribing or taking Hydrocortisone Activase Pharmaceuticals, several precautionary measures should be considered to minimize risks and ensure safe use.

• Assess adrenal function before initiating therapy and monitor cortisol levels during treatment.
• Use the lowest effective dose for the shortest duration necessary to control symptoms.
• Caution in patients with diabetes, hypertension, or a history of cardiovascular disease.
• Evaluate for existing infections; hydrocortisone may mask typical signs of infection.
• Avoid abrupt discontinuation to prevent adrenal crisis; tapering is recommended under medical supervision.
• Discuss potential effects on bone density with long‑term use and consider supplementation or monitoring.

Hydrocortisone can influence the activity of several other medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Avoid

• Concurrent use with potent CYP3A4 inducers such as rifampin, which may markedly lower hydrocortisone plasma concentrations.
• Co‑administration with strong CYP3A4 inhibitors like ketoconazole, which can increase systemic exposure and risk of side effects.

Use with caution

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal ulceration or bleeding.
• Anticoagulants, e.g., warfarin, may have enhanced anticoagulant effects, requiring closer INR monitoring.
• Vaccines, especially live attenuated vaccines, may have reduced efficacy or increased risk of infection.
• Diabetic medications may require dose adjustment due to hydrocortisone‑induced hyperglycemia.